Skip to content
Qvanteq
  • Home
  • Technology
    • Key benefits
    • Mechanism of Action
    • Publications
  • Products & Services
    • Neurovascular
    • Peripheral
    • Coronary
    • Other Devices
    • Consulting
  • About us
    • Management
    • Board of Directors
    • Quality system
    • Investors
  • News & Media
    • 2020
    • 2019
    • Archive
  • Contact
Qvanteq
2012News

zkb pionierpreis technopark 2012 finalist

Posted 3. April 20127. February 2018 qvanteq

Qvanteq was among the finalists of the Pionierpreis 2012. 15 companies have been nominated.

Post navigation

⟵Qvanteq in “20minuten”: “Weniger Herzinfarkte dank neuer Stent-Technologie”
CTI Start-Up Label⟶

Recent News

  • Stop the activation of the blood coagulation cascade by your medical device
  • Make any surface antithrombotic
  • Qvanteq is using MedtechVault
  • In-vitro thrombogenicity screening capacity
  • Qvanteq has moved to new offices

Qvanteq AG

Technoparkstr. 1, 8005 Zürich, Switzerland
+41 44 500 98 90
info@qvanteq.com

More

  • Meet us
  • Subscribe
  • Contact
  • Disclaimer
Copyright Qvanteq AG